News Column

YaFarm Technologies Announces World Class Lab in ISCI Stem Cell Center

Feb 8 2013 12:00AM

Marketwire

Tracker

PITTSTON, ME -- (Marketwire) -- 02/08/13 -- YaFarm Technologies, Inc. (OTC Pink: YFRM) (YaFarm, or the Company) announced today that the Integrative Stem Cell Institute (ISCI), a premier provider of point-of-care, stem cell- based therapies, is initiating design and development of a new, world-class cell processing and culture laboratory in Cancun, Mexico.

The Institute has begun construction of a class 10,000, ISO 7 clean room for the processing of autologous, mesenchymal cells for point-of-care therapies. "This lab is critical for the Institute," says Juan Castillo-Plaza, MD, founder of the ISCI. "As part of our commitment to patient safety, and our on-going clinical studies and research, we will be able to draw, process and then inject the patient's cells within the same facility."

The ISCI lab is part of a 2,000 sq ft facility that is housed in the Hospital Galenia in Cancun, Mexico. "This will be one of the most advanced laboratories in world," continues Castillo. The ISCI has brought in experts from around the world to both design the layout of the libratory space as well as develop standard operating procedures (SOPs) to assure the highest possible standards for quality assurance and quality control.

An essential element of the laboratory's design is the development of an innovative Cell Processing Program (CPP) to define the function and management of the facility. This process identifies specific processes for the selection, sorting and the differentiation of autologous progenitor cells, as well as the long-term cryo-preservation of these repair cells. The CPP has a vigorous quality assurance program built into it with on-going validation procedures, continuous quality control mechanisms, as well as robust record management and data storage systems.

The ISCI believes that the design and construction of this category of laboratory space within a hospital setting is critical for the continued advancement of the field of regenerative medicine. "And we are pleased to have this state-of-the-art facility in a hospital with the stature and quality as Hospital Galenia," continues Castillo. "It is the only hospital in Mexico that is accredited by both the Joint Commission International (JCI) and Accreditation Canada International (ACI)."

About Integrative Stem Cell Institute (ISCI)
The Integrative Stem Cell Institute (ISCI) is a premier provider of point-of-care, stem cell-based therapies for patients from around the world. With a state of the art laboratory housed within the Hospital Galenia in Cancun, Mexico, the ISCCI combines the most advanced scientific application of stem cells with second to none medical care within the structure of adaptive clinical trials to effective track long term outcomes and assure patient safety. More information on the Integrative Stem Cell Institute is available at www.iscelli.com

SAFE HARBOR STATEMENT

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition, adequate financing, and other material risks. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance, or achievements to be materially different from the statements made herein.



Contact:

The Integrative Stem Cell Institute
Contact:
Miranda Abrahams
Miranda@iscelli.com

Investor Contact
Atlanta Capital Partners, LLC
David Kugelman
(866) 692-6847
info@atlcp.com





Source: Marketwire